HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Behavioral and convulsant effects of the (S) enantiomer of the group I metabotropic glutamate receptor agonist 3,5-DHPG in mice.

Abstract
The purpose of the present studies was to investigate the behavioral and convulsant effects produced by the group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine (DHPG). Administered i.c.v. to mice, (S)-3,5-DHPG produced a behavioral syndrome consisting of scratching and/or facial grooming, tremors, slow forelimb clonus, rearing, and falling that increased over the dose range of 10-400 nmol. The full syndrome, produced by 400 nmol of (S)-3,5-DHPG, was antagonized by the selective mGlu1 receptor antagonist LY456236 but not by the mGlu5 receptor antagonist MPEP or the mGlu2/3 receptor antagonist LY341495. The behaviors induced by the 400 nmol dose were not blocked by the NMDA receptor antagonist MK-801, but were attenuated by the non-NMDA receptor antagonists GYKI 52466 and NBQX, and the Ca2+ mobilization inhibitor dantrolene, but at motor-impairing doses. The scratching behaviors produced by 30 nmol of (S)-3,5-DHPG were antagonized by LY456236 but not by MPEP, LY341495 or MK-801. GYKI 52466 and dantrolene, but not NBQX, inhibited scratching at motor-impairing doses. Both 400 and 30 nmol of (S)-3,5-DHPG produced a generalized seizure as recorded by surface EEG electrodes. LY456236 blocked the seizures produced by 30 nmol but not by 400 nmol; dantrolene was ineffective in blocking seizures produced by either dose. The present findings suggest that (S)-3,5-DHPG produces an increase in excitation that is mediated by mGlu1 and non-NMDA receptors.
AuthorsMatthew E Barton, Harlan E Shannon
JournalNeuropharmacology (Neuropharmacology) Vol. 48 Issue 6 Pg. 779-87 (May 2005) ISSN: 0028-3908 [Print] England
PMID15829250 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Convulsants
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • Resorcinols
  • 3,5-dihydroxyphenylglycine
  • Glycine
Topics
  • Animals
  • Behavior, Animal (drug effects)
  • Behavioral Symptoms (chemically induced, physiopathology)
  • Convulsants (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Electroencephalography (drug effects)
  • Excitatory Amino Acid Agonists (pharmacology)
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Glycine (analogs & derivatives, pharmacology)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Regression Analysis
  • Resorcinols (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: